secwatch / observer
8-K filed May 17, 2023, 7:59 PM ET ticker ZSQR CIK 0001759186
leadership confidence high sentiment neutral materiality 0.60

Coeptis Therapeutics appoints Brian Cogley as CFO; Christine Sheehy steps down

Z Squared Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Christine Sheehy

Chief Financial Officer
ZSQR · Z Squared Inc.
Effective
2023-05-17
Successor
Brian Cogley
Filed
May 17, 2023, 7:59 PM ET
On May 17, 2023, Coeptis Therapeutics, Inc. (NASDAQ GLOBAL: COEP) (the “Company”) announced that Christine Sheehy is stepping down from her role as Chief Financial Officer of the Company, effective immediately.
Appointed

Brian Cogley

Chief Financial Officer
ZSQR · Z Squared Inc.
Effective
2023-05-17
Filed
May 17, 2023, 7:59 PM ET
On May 17, 2023, the Company announced that Brian Cogley, age 37, was appointed as the Company’s new Chief Financial Officer, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Christine Sheehy departed as Chief Financial Officer at Z Squared Inc..

Action
stepping down
Role
Chief Financial Officer
Exact text from the filing
On May 17, 2023, Coeptis Therapeutics, Inc. (NASDAQ GLOBAL: COEP) (the “Company”) announced that Christine Sheehy is stepping down from her role as Chief Financial Officer of the Company, effective immediately.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Brian Cogley was appointed as Chief Financial Officer at Z Squared Inc..

Action
appointed
Role
Chief Financial Officer
Exact text from the filing
On May 17, 2023, the Company announced that Brian Cogley, age 37, was appointed as the Company’s new Chief Financial Officer, effective immediately.
View on SEC.gov

Z Squared Inc. filing history →

Source: SEC EDGAR
accession 0001683168-23-003496
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.